Meta tags:
keywords=;
description=;

Headings (most frequently used words):

you, about, to, exit, abbott, website, investors, newsroom, responsibility, careers, press, releases, are, for, another, country, or, region, specific, do, wish, continue, and, this, subscribe, consumers, healthcare, professionals, partners, contact, site, map, policies, privacy, policy, terms, conditions,

Text of the page (most frequently used words):
the (42), and (37), #cancer (27), abbott (25), for (23), cologuard (19), screening (19), with (14), colorectal (12), about (11), people (11), are (9), test (9), that (8), our (8), loading (7), 2026 (7), adults (7), colon (7), talk (7), this (6), plus (6), healthcare (6), campaign (6), can (6), jodie (6), sweetin (6), john (6), stamos (6), overview (6), you (5), have (5), site (5), all (5), more (5), tests (5), second (5), professionals (5), website (4), may (4), your (4), screen (4), privacy (4), com (4), crc (4), older (4), who (4), awkward (4), conversations (4), when (4), encouraging (4), share (4), press (4), responsibility (4), careers (4), faqs (4), products (3), not (3), approved (3), specific (3), without (3), further (3), health (3), policy (3), leading (3), than (3), even (3), average (3), risk (3), time (3), from (3), says (3), because (3), important (3), detected (3), how (3), easy (3), get (3), screened (3), take (3), content (3), releases (3), contact (3), consumers (3), subscribe (3), events (3), exit (2), please (2), requested (2), country (2), region (2), information (2), medical (2), devices (2), other (2), countries (2), another (2), product (2), its (2), trade (2), services (2), company (2), preferences (2), terms (2), conditions (2), policies (2), siegel (2), wagle (2), deaths (2), younger (2), jama (2), life (2), facebook (2), linkedin (2), fda (2), performance (2), noninvasive (2), options (2), disease (2), allowing (2), kit (2), home (2), special (2), preparation (2), has (2), used (2), survival (2), learn (2), thetalk (2), remind (2), simple (2), accessible (2), under (2), yet (2), one (2), most (2), early (2), cancers (2), know (2), actor (2), doctor (2), encourage (2), stay (2), their (2), back (2), favorite (2), uncle (2), sitcom (2), new (2), social (2), beloved (2), mar (2), reunite (2), newsroom (2), investors (2), glance (2), heritage (2), search (2), jobs (2), conferences (2), benefits (2), culture (2), students (2), working (2), news (2), yes, wish, continue, aware, intended, residents, particular, noted, result, contain, pharmaceuticals, uses, those, regions, also, optimized, size, unless, otherwise, specified, service, names, appearing, internet, trademarks, owned, licensed, subsidiaries, affiliates, use, any, trademark, name, dress, made, prior, written, authorization, except, identify, rights, reserved, read, legal, notice, details, submit, eventtype, pageurl, advertising, myabbott, consumer, data, media, lindsey, dickinson, 608, 690, 0383, financial, michael, comilla, 224, 668, 1872, source, clinician, brochure, exact, sciences, corporation, madison, itzkowitz, incremental, advances, excremental, detection, 2009, sep, 101, 1244, natl, inst, jemal, years, published, https, jamanetwork, journals, fullarticle, 2844189, jan, star, statistics, e70067, clin, references, global, leader, helps, live, fully, stages, portfolio, changing, technologies, spans, spectrum, businesses, diagnostics, nutritionals, branded, generic, medicines, 122, 000, colleagues, serve, 160, connect, youtube, instagram, building, success, raises, bar, features, novel, biomarkers, improved, laboratory, processes, enhanced, sample, stability, through, high, designed, reduce, likelihood, false, positives, helping, minimize, unnecessary, follow, colonoscopies, both, demonstrate, commitment, improving, access, outcomes, developed, collaboration, mayo, clinic, first, line, aged, revolutionized, detecting, dna, markers, blood, stool, associated, precancer, patients, complete, collection, off, return, lab, results, included, national, guidelines, american, society, 2018, preventive, task, force, 2021, since, inception, 2014, been, million, times, based, year, rates, watch, video, visit, had, loved, ones, vice, president, marketing, lean, skipping, delaying, serious, consequences, goal, taking, step, jeremy, truxal, increasingly, affecting, cases, rising, among, remains, powerful, tools, help, prevent, catch, treatable, rate, percent, clinical, study, well, many, pre, precancers, they, removed, before, advancing, but, start, right, comedian, director, plan, using, make, don, leave, house, seen, toll, want, others, top, highlights, option, prescribed, provider, shipped, directly, patient, own, schedule, dietary, changes, partnered, anyone, musician, really, doesn, myself, ahead, done, peace, mind, care, thank, yourself, later, brings, niece, duo, spoof, nostalgic, style, skit, while, feel, uncomfortable, discuss, too, delay, will, featured, across, platforms, nation, cause, related, number, killer, nyse, abt, today, announced, stop, avoiding, reuniting, itcom, family, members, comes, need, trusted, adult, advice, prnewswire, march, ill, park, potentially, 90s, nostalgia, combine, drive, close, download, res, stars, reunited, importance, show, age, photos, twitter, map, partners, fund, sustainability, impact, executive, team, experts, honors, contacts, governance, resources, stock, info, financials,

Text of the page (random words):
john stamos and jodie sweetin reunite for the second talk with cologuard tests encouraging colon cancer screening mar 24 2026 investors overview financials stock info resources news events governance newsroom news press releases press contacts honors experts executive team responsibility overview social impact sustainability abbott fund subscribe consumers consumers healthcare professionals healthcare professionals careers overview working with us professionals students our people and culture benefits faqs conferences events search jobs careers overview working with us professionals students our people and culture benefits faqs conferences events search jobs about abbott overview who we are our heritage abbott at a glance abbott faqs contact us responsibility subscribe about abbott overview who we are our heritage abbott at a glance abbott faqs contact us responsibility subscribe consumers healthcare professionals careers about abbott careers investors newsroom responsibility partners contact site map policies privacy policy terms conditions press releases back to press releases john stamos and jodie sweetin reunite for the second talk with cologuard tests encouraging colon cancer screening share content to facebook share content to linkedin share content to twitter photos 1 abbott jodie sweetin and john stamos mar 24 2026 take it from your favorite tv uncle at 45 it s time to talk to your doctor about simple screening for colon cancer with the cologuard test beloved sitcom stars jodie sweetin and john stamos reunited to share the importance of colorectal cancer screening and show how easy it can be for average risk adults age 45 to screen with a cologuard test download hi res close potentially awkward conversations and 90s nostalgia combine to drive accessible screening for adults 45 learn more at cologuard com thetalk abbott park ill march 24 2026 prnewswire abbott nyse abt today announced a new campaign encouraging people to stop avoiding awkward conversations about colorectal cancer the company is reuniting beloved s itcom family members john stamos and jodie sweetin for the second talk campaign because when it comes to colon cancer screening even adults need another trusted adult for advice the second talk brings back tv s favorite uncle and niece duo to spoof the talk for a nostalgic sitcom style skit to remind people that while colon cancer may feel uncomfortable to discuss screening is too important to delay the new campaign will be featured across social platforms encouraging adults 45 and older to get screened for colorectal cancer the nation s second leading cause of cancer related deaths 1 and the number one cancer killer of people under 50 2 i ve partnered with abbott to encourage anyone 45 and older to get screened for colon cancer says actor and musician john stamos it really doesn t have to be awkward i ve used the cologuard test myself to stay ahead of it easy done peace of mind take care of your health you ll thank yourself later the campaign highlights the cologuard test an fda approved noninvasive screening option for adults 45 and older who are at average risk for colorectal cancer the test is prescribed by a healthcare provider and shipped directly to a patient s home allowing people to screen on their own schedule without special preparation or dietary changes i m not 45 yet but i know how important it is to start screening for colorectal cancer right at 45 says actor comedian and director jodie sweetin i plan to talk to my doctor about using cologuard because i know how easy that can make it to get screened i don t even have to leave my house i ve seen the toll colorectal cancer can take and want to encourage others to stay on top of their health colorectal cancer is increasingly affecting younger adults with cases rising among people under 50 2 yet screening remains one of the most powerful tools to help prevent the disease or catch it early when it is most treatable when detected early colorectal cancer has a survival rate of 91 percent 3 in a clinical study the cologuard plus test detected 95 of all colon cancers as well as many pre cancers 4 when precancers are detected from screening they can be removed before advancing to cancer we ve all had awkward conversations with our loved ones says jeremy truxal vice president of marketing for screening abbott it s time to lean in on conversations about colorectal cancer because skipping or delaying screening can have serious consequences our goal with this campaign is to remind people that screening can be simple and accessible and that taking this step is important to watch the campaign video and learn more about colorectal cancer screening options visit cologuard com thetalk based on 5 year survival rates about the cologuard and cologuard plus tests developed in collaboration with mayo clinic the cologuard and cologuard plus tests are first line noninvasive colorectal cancer crc screening options for adults aged 45 or older who are at average risk for the disease the cologuard test revolutionized crc screening by detecting specific dna markers and blood in stool associated with cancer and precancer allowing patients to complete the collection kit at home without special preparation or time off and return the kit to the lab for results it is included in national screening guidelines from the american cancer society 2018 and the u s preventive services task force 2021 since its inception in 2014 cologuard has been used to screen for crc more than 23 million times building on this success the fda approved cologuard plus test raises the performance bar even further and features novel biomarkers improved laboratory processes and enhanced sample stability through high performance the cologuard plus test is designed to reduce the likelihood of false positives helping to minimize unnecessary follow up colonoscopies both tests demonstrate abbott s commitment to improving crc screening access and outcomes about abbott abbott is a global healthcare leader that helps people live more fully at all stages of life our portfolio of life changing technologies spans the spectrum of healthcare with leading businesses and products in diagnostics medical devices nutritionals and branded generic medicines our 122 000 colleagues serve people in more than 160 countries connect with us at abbott com and on linkedin facebook instagram x and youtube references siegel rl wagle ns star j et al colorectal cancer statistics 2026 ca cancer j clin 2026 e70067 siegel rl wagle ns jemal a leading cancer deaths in people younger than 50 years jama published jan 22 2026 https jamanetwork com journals jama fullarticle 2844189 itzkowitz s incremental advances in excremental cancer detection j natl cancer inst 2009 sep 16 101 18 1244 58 cologuard plus clinician brochure madison wi exact sciences corporation source abbott for further information abbott media lindsey dickinson 608 690 0383 abbott financial michael comilla 224 668 1872 policies terms conditions privacy policy consumer health data privacy policy myabbott privacy preferences advertising preferences pageurl eventtype submit 2026 abbott all rights reserved please read the legal notice for further details unless otherwise specified all product and service names appearing in this internet site are trademarks owned by or licensed to abbott its subsidiaries or affiliates no use of any abbott trademark trade name or trade dress in this site may be made without the prior written authorization of abbott except to identify the product or services of the company you are about to exit for another abbott country or region specific website please be aware that the website you have requested is intended for the residents of a particular country or region as noted on that site as a result the site may contain information on pharmaceuticals medical devices and other products or uses of those products that are not approved in other countries or regions the website you have requested also may not be optimized for your specific screen size do you wish to continue and exit this website yes no loading loading loading loading loading loading loading